Mackey Edward F 4

4 · BOSTON SCIENTIFIC CORP · Filed Feb 22, 2022

Form 4

Period: 2022-02-17

EVP, Operations

Transactions

Tax Payment
Common Stock
2022-02-17$42.83/sh−832$35,635→ 34,435 total
Exercise/Conversion
Common Stock
2022-02-18+2,223→ 60,377 total
Exercise/Conversion
Restricted Stock Units
2022-02-17−2,833→ 8,500 total
Exp: 2025-02-17→ Common Stock (2,833 underlying)
Tax Payment
Common Stock
2022-02-18$42.55/sh−10,310$438,690→ 50,067 total
Exercise/Conversion
Deferred Stock Units
2022-02-18−23,719→ 0 total
Exp: 2022-02-18→ Common Stock (23,719 underlying)
Exercise/Conversion
Deferred Stock Units
2022-02-18−2,223→ 4,448 total
Exp: 2024-02-18→ Common Stock (2,223 underlying)
Exercise/Conversion
Common Stock
2022-02-17+2,833→ 35,267 total
Exercise/Conversion
Common Stock
2022-02-18+23,719→ 58,154 total

Footnotes (5)

[F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
[F4]Shares of common stock will be issued to the reporting person in one installment on February 18, 2022, the second anniversary of the date of grant.
[F5]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.

Documents

1 file